Tag Archives: vaccine

Kylie Quinn, RMIT University This week, US health authorities recommended pausing the rollout of the one-shot Johnson & Johnson/Janssen COVID-19 vaccine while investigations into exceptionally rare blood clots take place. Six women suffered blood clots out of nearly seven million doses administered. The J&J vaccine uses broadly similar vaccine technology as the AstraZeneca vaccine, known as adenoviral vectors, which has …

Shutterstock / Seda Servet Carmen Álvarez Domínguez, UNIR – Universidad Internacional de La Rioja Reino Unido se ha convertido en el primer país en aprobar la vacuna de Pfizer, con el objetivo de comenzar la vacunación dentro de diez días. Lo ha hecho así porque Reino Unido tiene su propia agencia del medicamento, la MHRA, y puede hacer uso de …

The pandemic rages as the world waits for COVID-19 vaccines. Peter Zelei Images/Getty Images William Petri, University of Virginia There are now two COVID-19 vaccines that, at least according to preliminary reports, appear to be 94.5% and 95% effective. Both were developed in a record-breaking 11 months or so. I am an infectious diseases specialist and professor at the University …

The TRIPS waiver enables WTO member states to manufacture and distribute COVID-19 drugs and medical supplies that would normally be protected by patents. (Pixabay) Ronald Labonte, L’Université d’Ottawa/University of Ottawa and Mira Johri, Université de Montréal Since the birth of the World Trade Organization (WTO) in 1995, most member states have had to abide by the Agreement on Trade Related …

file x ov. niversity of Maryland School of Medicine/AP/AAP Harry Al-Wassiti, Monash University; Colin Pouton, Monash University y Kylie Quinn, RMIT University La empresa de biotecnología alemana BioNTech y la farmacéutica estadounidense Pfizer anunciaron el lunes los primeros resultados prometedores de su ensayo clínico de fase 3 para una vacuna contra el SARS-CoV-2, el virus que causa la covid-19. Estos …

Numstocker/Shutterstock Rebecca Ashfield, University of Oxford A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal. We have published early results from our clinical trial of the vaccine ChAdOx1 nCoV-19 (also known as AZD1222), designed by the University of Oxford and …

Numstocker/Shutterstock Rebecca Ashfield, University of Oxford A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal. Today, we published early results from our clinical trial of the vaccine ChAdOx1 nCoV-19 (also known as AZD1222), designed by the University of Oxford and …